hPG(80) (Circulating Progastrin), a Novel Blood-Based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated Neuroendocrine Tumors

SIMPLE SUMMARY: Current blood-based biomarkers for neuroendocrine neoplasms (NENs) lack both sensitivity and specificity. Human circulating progastrin (hPG(80)) can be easily measured in plasma by ELISA. This study is the first to examine hPG(80) in NENs. The study demonstrated increased levels of h...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Aman, Prieur, Alexandre, Kolesar, Jill, Arnold, Susanne, Payen, Léa, Mahi, Younes, Vire, Berengere, Sands, Madison, Evers, B. Mark, Joubert, Dominique, Anthony, Lowell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870162/
https://www.ncbi.nlm.nih.gov/pubmed/35205614
http://dx.doi.org/10.3390/cancers14040863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870162/
https://www.ncbi.nlm.nih.gov/pubmed/35205614
http://dx.doi.org/10.3390/cancers14040863

Ejemplares similares